| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |